BackgroundImmunotherapy combined with chemotherapy has improved outcomes in advanced gastric cancer (GC), but reliable biomarkers to predict clinical benefit remain limited. Metabolomics provides a co
native top-down MS data of human protamines collected on orbitrap fusion lumos. Samples were collected from different patient populations, namely normal, asthenozoospermia, and oliogoasthenozoospermia
